Hubert Fornalik, MD, FACOG, is a gynecologic oncologist at Goshen Center for Cancer Care. He specializes in ovarian cancer debulking, or tumor removal, robotic/minimally invasive surgery, sentinel node biopsies, and nerve sparing radical hysterectomies. Dr. Fornalik treats patients with uterine, ovarian, cervical and vaginal cancers. He also treats patients with pelvic masses and high-risk patients with benign gynecological conditions.
Philosophy of Care
Dr. Fornalik believes in the importance of giving patients hope, and working hard to give each patient every possible chance of success. He understands that our goals are as unique as our personalities and change as we go through different stages of our lives. Dr. Fornalik works closely with patients to develop individual treatment plans most suitable to the patient’s prior medical history, diagnosis and goals. Dr. Fornalik performs 90 percent of his major cases robotically, compared to a 65 percent specialty average. Robotic surgeries offer shorter hospital stays and quicker recovery than traditional open surgeries. Dr. Fornalik considers maximal effort cytoreductive surgery with the goal of removing all visible cancer for patients with advanced cancers.
Dr. Fornalik has focused on the following treatment areas: treatment of gynecologic cancers, implementation of novel surgical approaches and chemotherapy, intraperitoneal chemotherapy for ovarian cancer and complex surgery for benign gynecologic conditions. His expertise in robotic and debulking surgery in combination with chemotherapy and radiation, allows him to offer a unique approach to patients with recurrent cancers.
Dr. Fornalik is well published in the areas of endometrial, uterine and ovarian cancers. He has special research interests in the use of robotic assisted surgery in treatment, as well as the effects of obesity on prognosis and surgical outcomes. In his last publication in International Journal of Gynecologic Cancer (2015; 25: 1488-1493), he presented a novel approach to staging of ovarian and high-risk uterine cancers, which became the first report of robotic hand-assisted surgery in gynecology.